Weight LossFDA Approved
Pramlintide
Also known as: Symlin
The synthetic amylin analog FDA-approved as adjunctive therapy with insulin, the biochemical forerunner to cagrilintide.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~48 minutes
Typical Dose
60–120 mcg with meals
Administration
Subcutaneous injection
Mechanism of Action
Recreates the body's natural bi-hormonal response to feeding by slowing gastric emptying, suppressing glucagon, and promoting satiety.
Key Research Areas
diabetesamylinFDA approvedinsulin adjunct
Frequently Asked Questions
What is Pramlintide?▾
The synthetic amylin analog FDA-approved as adjunctive therapy with insulin, the biochemical forerunner to cagrilintide.
How does Pramlintide work?▾
Recreates the body's natural bi-hormonal response to feeding by slowing gastric emptying, suppressing glucagon, and promoting satiety.
What is the recommended dosage for Pramlintide?▾
The typical research dosage is 60–120 mcg with meals, administered via Subcutaneous injection. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Pramlintide?▾
The half-life of Pramlintide is approximately ~48 minutes. This affects dosing frequency and timing in research protocols.
Is Pramlintide FDA approved?▾
Yes, Pramlintide is FDA approved for specific medical indications. Consult your physician for proper medical guidance.
Research Disclaimer
The information provided about Pramlintide is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.